Tom E. Verstraelen
About
Tom E. Verstraelen is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine.
According to data from OpenAlex, Tom E. Verstraelen has authored 25 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 2 papers in Molecular Biology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Tom E. Verstraelen's work include Cardiac electrophysiology and arrhythmias (15 papers), Cardiomyopathy and Myosin Studies (13 papers) and Cardiac pacing and defibrillation studies (11 papers). Tom E. Verstraelen is often cited by papers focused on Cardiac electrophysiology and arrhythmias (15 papers), Cardiomyopathy and Myosin Studies (13 papers) and Cardiac pacing and defibrillation studies (11 papers). Tom E. Verstraelen collaborates with scholars based in Netherlands, Germany and United Kingdom. Tom E. Verstraelen's co-authors include Arthur A.M. Wilde, Aeilko H. Zwinderman, Maarten P. van den Berg, Paul A. van der Zwaag, Rudolf A. de Boer, Folkert W. Asselbergs, Freyja H.M. van Lint, Hidde Bleijendaal, Laurens P. Bosman and Lucas A. Ramos and has published in prestigious journals such as European Heart Journal, Statistics in Medicine and JACC. Cardiovascular imaging.
In The Last Decade
Tom E. Verstraelen
23 papers receiving 331 citations
Peers
Tom E. Verstraelen
Arjan Sammani Netherlands
Nathaniel Diamant United States
Amro Alsaid United States
Stefan van Duijvenboden United Kingdom
Yuri Ahuja United States
Т. М. Первунина Russia
Matthew M. Kalscheur United States
Pulkit Singh United States
Hidde Bleijendaal Netherlands
Shenqi Jing China
Citations per year, relative to Tom E. Verstraelen Tom E. Verstraelen (= 1×)
peers
Arjan Sammani
Countries citing papers authored by Tom E. Verstraelen
Since
Specialization
Citations
This map shows the geographic impact of Tom E. Verstraelen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom E. Verstraelen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom E. Verstraelen more than expected).
Fields of papers citing papers by Tom E. Verstraelen
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Tom E. Verstraelen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom E. Verstraelen. The network helps show where Tom E. Verstraelen may publish in the future.
Co-authorship network of co-authors of Tom E. Verstraelen
This figure shows the co-authorship network connecting the top 25 collaborators of Tom E. Verstraelen. A scholar is included among the top collaborators of Tom E. Verstraelen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom E. Verstraelen. Tom E. Verstraelen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Cox, Moniek G.P.J., Tom E. Verstraelen, Remco de Brouwer, et al.. (2025). The role of comorbidities and lifestyle factors in disease progression of phospholamban cardiomyopathy. European Journal of Preventive Cardiology. 33(2). 297–300.
2.
Verstraelen, Tom E., et al.. (2025). Personalized sudden cardiac death risk prediction in genetic heart diseases: Beyond one-size-fits-all. Heart Rhythm. 23(1). e62–e74.
3.
Leur, Rutger R van de, Remco de Brouwer, Hidde Bleijendaal, et al.. (2024). ECG-only explainable deep learning algorithm predicts the risk for malignant ventricular arrhythmia in phospholamban cardiomyopathy. Heart Rhythm. 21(7). 1102–1112.
4.
Lingen, Anne‐Lotte C.J. van der, Tom E. Verstraelen, Lieselot van Erven, et al.. (2024). Assessment of ICD eligibility in non-ischaemic cardiomyopathy patients: a position statement by the Task Force of the Dutch Society of Cardiology. Netherlands Heart Journal. 32(5). 190–197.
5.
Verstraelen, Tom E., Freyja H.M. van Lint, Remco de Brouwer, et al.. (2024). Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study. EP Europace. 26(4).
6.
Lint, Freyja H.M. van, Tom E. Verstraelen, Weijia Wang, et al.. (2023). Exercise does not influence development of phenotype in PLN p.(Arg14del) cardiomyopathy. Netherlands Heart Journal. 31(7-8). 291–299.
7.
Taha, Karim, Rutger R van de Leur, Thomas P. Mast, et al.. (2023). Deep neural network-based clustering of deformation curves reveals novel disease features in PLN pathogenic variant carriers. The International Journal of Cardiovascular Imaging. 39(11). 2149–2161.
8.
Theuns, Dominic A.M.J., Tom E. Verstraelen, Peter Paul H.M. Delnoy, et al.. (2022). Implantable defibrillator therapy and mortality in patients with non-ischaemic dilated cardiomyopathy. Netherlands Heart Journal. 31(3). 89–99.
9.
Bourfiss, Mimount, Anneline S.J.M. te Riele, Karim Taha, et al.. (2022). Exploring the Correlation Between Fibrosis Biomarkers and Clinical Disease Severity in PLN p.Arg14del Patients. Frontiers in Cardiovascular Medicine. 8. 802998–802998.
10.
Verstraelen, Tom E., Erik Buskens, Pascal F.H.M. van Dessel, et al.. (2022). Hospital utilisation and the costs associated with complications of ICD implantation in a contemporary primary prevention cohort. Netherlands Heart Journal. 31(6). 244–253.
11.
Wesselink, Robin, Ingrid Overeinder, Jolien Neefs, et al.. (2022). A failed catheter ablation of atrial fibrillation is associated with more advanced remodeling and reduced efficacy of further thoracoscopic ablation. Revista Española de Cardiología (English Edition). 76(6). 417–426.
12.
Ree, Martijn H. van der, Jeroen Vendrik, Tom E. Verstraelen, et al.. (2021). The β-angle can help guide clinical decisions in the diagnostic work-up of patients suspected of Brugada syndrome: a validation study of the β-angle in determining the outcome of a sodium channel provocation test. EP Europace. 23(12). 2020–2028.
13.
Verstraelen, Tom E., Pascal F.H.M. van Dessel, Lucas V.A. Boersma, et al.. (2021). Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort. Journal of the American Heart Association. 10(7). e018063–e018063.
14.
Brouwer, Remco de, Laura M.G. Meems, Tom E. Verstraelen, et al.. (2021). Sex-specific aspects of phospholamban cardiomyopathy: The importance and prognostic value of low-voltage electrocardiograms. Heart Rhythm. 19(3). 427–434.
15.
Bleijendaal, Hidde, Lucas A. Ramos, Tom E. Verstraelen, et al.. (2021). Improving electrocardiogram-based detection of rare genetic heart disease using transfer learning: An application to phospholamban p.Arg14del mutation carriers. Computers in Biology and Medicine. 131. 104262–104262.
16.
Taha, Karim, Wouter P. te Rijdt, Tom E. Verstraelen, et al.. (2020). Early Mechanical Alterations in Phospholamban Mutation Carriers. JACC. Cardiovascular imaging. 14(5). 885–896.
17.
Bleijendaal, Hidde, Lucas A. Ramos, Tom E. Verstraelen, et al.. (2020). Computer versus cardiologist: Is a machine learning algorithm able to outperform an expert in diagnosing a phospholamban p.Arg14del mutation on the electrocardiogram?. Heart Rhythm. 18(1). 79–87.
18.
Bosman, Laurens P., Tom E. Verstraelen, Freyja H.M. van Lint, et al.. (2019). The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update. Netherlands Heart Journal. 27(10). 480–486.
19.
Dijkgraaf, Marcel G. W., Michiel Hulleman, Lucas V.A. Boersma, et al.. (2017). Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator. Netherlands Heart Journal. 25(10). 574–580.
20.
Verstraelen, Tom E., Rachel M.A. ter Bekke, Paul G.A. Volders, Ad Masclee, & Joanna W. Kruimel. (2015). The role of the SCN 5A ‐encoded channelopathy in irritable bowel syndrome and other gastrointestinal disorders. Neurogastroenterology & Motility. 27(7). 906–913.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Arjan Sammani Breakdown of academic impact, for papers by Nathaniel Diamant Breakdown of academic impact, for papers by Amro Alsaid Breakdown of academic impact, for papers by Stefan van Duijvenboden Breakdown of academic impact, for papers by Yuri Ahuja Breakdown of academic impact, for papers by Т. М. Первунина Breakdown of academic impact, for papers by Matthew M. Kalscheur Breakdown of academic impact, for papers by Pulkit Singh Breakdown of academic impact, for papers by Hidde Bleijendaal Breakdown of academic impact, for papers by Shenqi Jing